Stocks · Health care · Pharmaceutical Preparations

SUPERNUS PHARMACEUTICALS, INC.

SUPN Clue Score33
United States Fiscal year ends December CIK 0001356576 Results filed 29 Oct 2026

What the insiders did No buying or selling

By person

11 insiders · 0 transactions
46.6×

Jack A. Khattar holds 46.6 times base salary in stock. $48.36M of shares against $1.04M in salary for 2025.

Salary from the company's own proxy. The shares are what Jack A. Khattar last reported holding, valued at $50.48, the price Common Stock was last bought or sold at on the open market here, on 18 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Jack A. Khattar
President, CEO
—
—
—
958,100
1.65%
$48.36M
−67.0%
Georges Gemayel
Director
—
—
—
0
0.0000%
$0.00
−100.0%
Jonathan Rubin
SVP, Chief Medical Officer
—
—
—
0
0.0000%
$0.00
−100.0%
Padmanabh P. Bhatt
Sr. VP of IP, CSO
—
—
—
0
0.0000%
$0.00
−100.0%
Frank Mottola
SVP, Chief Tech. Ops. Officer
—
—
—
0
0.0000%
$0.00
−100.0%
Timothy C Dec
Senior Vice-President & CFO
—
—
—
0
0.0000%
$0.00
−100.0%
Frederick M. Hudson
Director
—
—
—
0
0.0000%
$0.00
−100.0%
William Todd Horich
SVP, Commercial Operations
—
—
—
0
0.0000%
$0.00
−100.0%
Charles W Newhall III
Director
—
—
—
0
0.0000%
$0.00
−100.0%
Carrolee Barlow
Director
—
—
—
0
0.0000%
$0.00
−100.0%
Bethany Sensenig
Director
—
—
—
0
0.0000%
$0.00
—